about
Modeling the control of trypanosomiasis using trypanocides or insecticide-treated livestockA general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation.Modelling the use of insecticide-treated cattle to control tsetse and Trypanosoma brucei rhodesiense in a multi-host population.Modelling the long-term impacts on affected children of adult HIV: benefits, challenges and a possible approach.Evaluating the impact of two training interventions to improve diagnosis and case-management of malaria and pneumonia in Uganda.Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach.Modeling the joint epidemics of TB and HIV in a South African township.Stability analysis of a model for HIV infection with RTI and three intracellular delays.A general model for mortality in adult tsetse (Glossina spp.).On the relationship between age, annual rate of infection, and prevalence of mycobacterium tuberculosis in a South African township.Optimal control analysis of a malaria disease transmission model that includes treatment and vaccination with waning immunity.Mathematical model of tumor-immune surveillance.Mathematical modeling of bone marrow--peripheral blood dynamics in the disease state based on current emerging paradigms, part I.Growth rate and basic reproduction number for population models with a simple periodic factor.Modelling the effect of bednet coverage on malaria transmission in South Sudan.Mathematical Modeling of Bone Marrow - Peripheral Blood Dynamics in the Disease State Based on Current Emerging Paradigms, Part IIAnalysis of an HIV model with distributed delay and behavior changeEnhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysisOn a three-stage structured model for the dynamics of malaria transmission with human treatment, adult vector demographics and one aquatic stageAssessing the role of climate factors on malaria transmission dynamics in South SudanMesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
P50
Q28483695-1537B86F-EA13-424F-88E2-DAC3F206520EQ30566307-FD491039-546B-493D-BF36-5B10DF17E375Q34407698-336A460D-D181-4D56-B46E-E12C2C645D6DQ38225905-0EFA5B97-E161-4050-997D-E6132571367CQ38852887-042DBC5C-1002-4E94-A940-52BD0057DA77Q41932925-30D3CDDA-8F81-48FB-BE68-B381221FC21FQ46117831-03FA53FE-CBC9-4198-BCD0-6DB0159B9ECFQ46140311-A87CA308-F7D5-400E-A9FF-087557759FB1Q46344680-21EF6D96-82F3-4E88-B193-FCE1E8DB2842Q46822767-6B2DEBE7-A93D-4647-B3A3-8B300F0120FAQ47988165-7931A0C0-6C3C-47F1-8BA4-F065653F6D66Q50625185-59A1773A-EF4A-4F6D-B6FC-771B751F9257Q50712827-FE95B04C-C356-41C3-8A9F-2F815274A46CQ51906494-69B932A2-A346-4BF1-A45D-87DFAF53F95AQ55251053-BF3E90FE-AA5D-4D3B-B992-6833A80B3230Q57185165-7783BC6F-4F61-463A-94F9-724DC217F8B7Q58868338-DD09598E-BC00-4A0B-A00A-495238EF1A9CQ59351273-81135FBD-A2EF-46F6-9B05-E4FBD4BA3B46Q70721658-B887D051-53AA-426F-B27A-CEC08C3AB3EAQ91317090-BB789F51-8AF9-42A6-A542-9A70AB8F29E4Q92712104-3B349387-9FC6-4DF4-822F-8B6CF0D0D3DE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rachid Ouifki
@ast
Rachid Ouifki
@en
Rachid Ouifki
@es
Rachid Ouifki
@nl
Rachid Ouifki
@sl
type
label
Rachid Ouifki
@ast
Rachid Ouifki
@en
Rachid Ouifki
@es
Rachid Ouifki
@nl
Rachid Ouifki
@sl
prefLabel
Rachid Ouifki
@ast
Rachid Ouifki
@en
Rachid Ouifki
@es
Rachid Ouifki
@nl
Rachid Ouifki
@sl
P1053
A-4064-2017
P106
P1153
22986222600
P21
P31
P3829
P496
0000-0001-7697-1792